{"name":"Cell>Point LLC","slug":"cell-point-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBjOEFZS0J6Qk9MNnp3SW5JVFo4WXRGUkpwY3JXUDZlOW42SFFjY0F3TkNyNGM1enNGaGlMamotRzF4bnZFN1VYTU9ZakpPMTBxTkptR2Z2enEyX1dZb1Bv?oc=5","date":"2025-07-26","type":"pipeline","source":"Nature","summary":"A genetically encoded biosensor for point-of-care and live-cell detection of - Nature","headline":"A genetically encoded biosensor for point-of-care and live-cell detection of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxONkliVTRiR0VxcjM3YV9sSVIzRERMR2ZqandqMTRRTnFFU29Sd1BnbXkzbHJTUzM5RXdjbERVVFRhNy1DYld0SGR0N3hBTnBrUWc0cS1SVG5WajJEc3BfTUs1TTdVXzdQY1dvQmZZQnZGTjAxR21KMGJQejFzRjhHUERLcFlSZ2dVR28zMHpXUjZId1lRWmxRcXlvTTVFTVg4bzRXVEtWM3ZrbzNVZ0FxcFBkV3QtakV6R1kxNg?oc=5","date":"2025-06-23","type":"pipeline","source":"Fierce Biotech","summary":"Otsuka pens $670M pact to point Harbour's preclinical T-cell engager toward autoimmune disease - Fierce Biotech","headline":"Otsuka pens $670M pact to point Harbour's preclinical T-cell engager toward autoimmune disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE40eXYwdnpNR2JtWUlJVmRiMEN3ZVdVWEZTVnIwLU9YUkVUaGtMUWNKTl9kNWF3b2R1Rl9MN3FXREgzNGNITDhDRk5pY3RMdXAwd1Jtd3J3c2xIemwzMFVF?oc=5","date":"2025-01-13","type":"pipeline","source":"Nature","summary":"Prognostic, biological, and structural implications of FLT3 -JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies - Nature","headline":"Prognostic, biological, and structural implications of FLT3 -JMD point mutations in acute myeloid leukemia: an analysis ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmlsWVI2TFR1TlVJd1JWTnpSbURvUE4xQlF0SXFUcHc5SVRQOHdxVm9tX193Z1hUdzFscnRYeUd6VHF6UVZhUnBYX2VDNGltc1pNenZIRkZPbzJSWmFrWjI1SEliem12Qlhyd201SmJxUTYxRmdDaG45VDFPX0ExMElxYzJhaHd2RFJ4enpwTUx1T2dXbHQxLVY1UEhfRWFyVUVGQW1yY0F1UEMtRFRWbEF6MkpiU0k?oc=5","date":"2024-09-24","type":"deal","source":"Fierce Pharma","summary":"Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy production tech - Fierce Pharma","headline":"Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy production tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxObkZVbnJndzdqaTJ1dmIyT0hnbXF6bkw2Rl9ySmk3YkpaNGlrbnhpRVhPeFJodEVycTlkWnI0akdHdWdPa1NZQndkWjVSOUtWZl9zQk5hVXJ6NjRncTVqQTA4ejgtYXRRWi1sTHBpVmtaSmxYZWplUGRRMEg5bzFLNVpSd2UyWm1hSGc1eno5LWFrZGpZZXRmMlRKLVlmNl92N0NGQWplYXBtcW9yTm9OaTk4aFNYelRWTmNCb0Y4cUpjRm5T?oc=5","date":"2024-05-15","type":"deal","source":"Fierce Pharma","summary":"With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide - Fierce Pharma","headline":"With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNdXJRcUc1Q1U4TVVSeW1UOFd5b2tneDVNX3VhaTFTcE1fZnQxUi1KT1Fwb0E1Q0Jwa3Njb2RRY1BwenV5cUpkWm1Ia2xrOFpsT3ZQenFuU3oyZjBoeWxKOEV5RUNaLUZtTVdiaGxEeS1DTUFYZ2NnekJnWkFiaTJuRHFRTy1WdzNYWVhkaTBpSWRlZVN1dXBkZnlPa0hFakZmQl9OdzQ4LW9OUThLSC10THg3ZXBHN1NBaWJuOHFYdnhwN2lzZldSRy0wOC1aN0VkejVweWhTVlVBZXRuaFFGaVVma2Y1ZzBUUTRrdTJIcU9ubVhJZUE?oc=5","date":"2023-10-03","type":"deal","source":"prnewswire.com","summary":"Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies - prnewswire.com","headline":"Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNN1o2VTBTbWczbHU0QVU5Ri02Qml0UUQzdERiRFdkcExTbVF5bEI2SnlDek9YT09ucjFGeTBRY2hQNjFtSmZRMzBCX251bDBuZ3dQVE56SmU4eVIyYkVWUDBsdUh3Yk5aemZqeEotbDdMVnpXOWZrQ1JUcVBpeWFMa2ZiQklFR2dPTzFjZlVrdWdTak10V0FDQVR1MktfUDRHVEZIME5meWJZalhJS083d0xULUVFS01ycmFwX3Nn?oc=5","date":"2023-04-11","type":"pipeline","source":"Fierce Biotech","summary":"GSK pays out £30M to Adaptimmune as cell therapy work officially wraps up - Fierce Biotech","headline":"GSK pays out £30M to Adaptimmune as cell therapy work officially wraps up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNUUZmQmcyelplbDNxdUlKSVBrYlBJUFlKQ3NVX0xCTG9ZVW1HNkRNQkFQdVlQUmJ0eC1pTkF6N2UxdmRmMnprLWQ1Uk80SGFFcTRhX1B5N3FIU3M5eWlkN2w3MnM1NTRvSXpzWV9UMFZ2MlNRc0JSN0tpRjZuVEdMLUZ3SE9hZ04weGZXWmt4enVUWGpYekpUWDZnNU1BUDVGZzV6T21LbXRSVVhIT09PN3hyTkdaU1FPUndEZjRvMkE3QUlIM2Qxam1wVmduN3FHQ21ZNWJvcUZoUE9tWUdOdEd5Nld3akNZRWZ3aHdPX2JUV1BSdTVSbGpQVnY3Y2NF?oc=5","date":"2022-06-21","type":"deal","source":"GlobeNewswire","summary":"Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies - GlobeNewswire","headline":"Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNbnpDcEVHc0dMdVFhWHFSSWs4MkEyT0JOVTIyeWd0blBZY2R4cTNQS3VfSjFSN1VtX2Q3OGVxV0Nia2ZSM3B4bDU3Sm1ibi1ERzJ5NWNZaEZHYWJ3ekg2SlZZQlIyeklvWmN6TU1ROXo3NHBpWW94RmMybXpELTdWNnpnMm5qN2cyWFp2MnR0WDgzQ1RIVWNtbQ?oc=5","date":"2022-06-03","type":"deal","source":"Fierce Biotech","summary":"UPDATE: Bristol Myers strikes up Roche rivalry with $4.1B Turning Point buy - Fierce Biotech","headline":"UPDATE: Bristol Myers strikes up Roche rivalry with $4.1B Turning Point buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOTlBDZEFJZ1poX1BJaElvN0ZrTjNBNE0yT3YwblF2TWUyUXVHZElsSFpuSjRUUWcxUzRKc3lpaTJ3cjNUZXBOVVl3TnhOSENFZU5BblRMZl92VzVSSFBEMDZtNzNTMnRHdnVXZVR5N0tOUWNQX3pJWmowY0dtRjdLb2VveGdJb2R4SmsxUmxjUmI3QlBNZ3c?oc=5","date":"2022-03-16","type":"pipeline","source":"The Denver Post","summary":"SEC claims Colorado biotech firm bilked investors, allegations the company denies - The Denver Post","headline":"SEC claims Colorado biotech firm bilked investors, allegations the company denies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeXJHbUVLX3V2aktqR0wzS2JjYW9vYVpvYWJhNjU2MUhYc1hDSUV6NFl6S01vbnJVZEsxbU4zMWg0ZmtUUnM2elUtOFI0WUpFWGplM2JYaFNpY3FObDVtVGEtT0JnRUs3LWdKLXJ5Vy1GenlHQm9lQzJ6c3k1bWtfbUktalN4QXo2MHhRLUZKX0N3RGZHNnR6dVdSY0RDZ2h3RFhBeDRmU2FQbnNPVjhLcGp2d21PY2l3WUFzNU1KMlA?oc=5","date":"2022-01-12","type":"pipeline","source":"Fierce Pharma","summary":"Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservices - Fierce Pharma","headline":"Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQcEZ6cklZYXRUeEpBdUNjNnpSUGxEZ3J5ckZzOElhemtiN2dXemR5b3NEOVZkMEpVSHVBQ0NrR082SEdGN2dzbWsteV9HbktDVnRxLUxtVmg3MTI3RUY4WkVXSVZpLWFQWDVJMWNFVjg4ckM0MEphWUZ3dUlKUGhKXzM3MTVoeXhXN1lTcWN5Q1FkTkE0SkJwRTBzUzBrY3o4NjQ3dDYyeXoxajA?oc=5","date":"2021-06-11","type":"pipeline","source":"Reuters","summary":"IN BRIEF: SEC says biotech firm defrauded investors of $10 mln - Reuters","headline":"IN BRIEF: SEC says biotech firm defrauded investors of $10 mln","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}